In this free webinar, the featured speakers will discuss which Covid-19 tests are available and the limitations they hold. Aimed at those who are trying to finalize their Covid-19 protocols, this webinar is intended to help choose the assay type that fits the objectives of the study best. Learn about which research-specific tests to choose from as well as the Covid-19 mutation and the obstacles we face.

Are you using the right Covid-19 test? In the race to contain the COVID-19 pandemic, efficient detection of SARS-CoV-2 was and still remains the cornerstone. On January 23, the first in-house RT-PCR assay was published, quickly followed by the development of multiple commercial kits.

During the webinar, a Cerba biologist will walk participants through the overview of our serological testing, discuss the reliability of tests, the current limits in Covid-19 testing, and which sample is the most efficient in each case for clinical trials.

Lastly, Cerba Research’s partner Fulgent will discuss NGS testing and how much we know about the analysis of the virus and its mutations.

Join Benedicte Roquebert, PhD Biologist, Cerba Research, Stéphanie Haim-Boukobza, PhD Biologist, Cerba Research and Yan Meng, PhD Biologist, Fulgent Genetics in a live webinar on Monday, June 15, 2020 at 1pm EDT.